![](/img/cover-not-exists.png)
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
Banerjee, S., Rustin, G., Paul, J., Williams, C., Pledge, S., Gabra, H., Skailes, G., Lamont, A., Hindley, A., Goss, G., Gilby, E., Hogg, M., Harper, P., Kipps, E., Lewsley, L.-A., Hall, M., Vasey, P.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mds494
Date:
March, 2013
File:
PDF, 301 KB
english, 2013